Reuters logo
BRIEF-Faron says ‍U.S. FDA proposes direct BLA submission for traumakine
September 4, 2017 / 6:32 AM / 2 months ago

BRIEF-Faron says ‍U.S. FDA proposes direct BLA submission for traumakine

Sept 4 (Reuters) - FARON PHARMACEUTICALS OY:

* ‍U.S. FDA PROPOSES PROCEEDING DIRECTLY TO BLA SUBMISSION FOR TRAUMAKINE ® FOLLOWING COMPLETION OF EUROPEAN AND JAPANESE PHASE III STUDIES​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below